Related Experiment Video
Updated: Feb 16, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Hepatitis C: clinical and biological features related to different forms of cocaine use
Silvia Bassani Schuch-Goi1, Juliana Nichterwitz Scherer1, Felix Henrique Paim Kessler1
1Centro de Pesquisas em Álcool e Drogas, Centro Colaborador em Álcool e Drogas HCPA/SENAD, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
Introduction:
Hepatitis C virus (HCV) infection is related with several liver diseases such as cirrhosis and hepatocellular carcinomas, leading to more than 0.5 million deaths every year and to a great global burden. It is known that injection drug users show a high prevalence of HCV infection, being considered a risk group for this disease. Cocaine users seem to be in greater risk than other drug users, and several hypotheses for this association are being studied.
Aim:
To review data on HCV infection in cocaine users, taking into consideration the relevance of the different routes of drug administration and other risk behaviors.
Methods:
This was a narrative review performed in the main scientific databases.
Results And Conclusion:
Data suggest that cocaine use could be associated with HCV infection due to the specificities of cocaine consumption pattern, even in those subjects who do not inject drugs, in addition to other risky behaviors, such as tattooing and unprotected sex. Injectable cocaine users seem to be more susceptible to contamination than users who do not inject drugs. However, evidence is pointing to the possibility of infection by sharing drug paraphernalia other than syringes. Moreover, specific immune system impairments caused by cocaine use are also being linked with HCV infection susceptibility, persistence and increased pathological effects.
Related Concept Videos
Hepatic Drug Excretion: Influencing Factors
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Toxicity: Risk factors
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

